Alexander Aivazidis | PhD Student

Aivazidis, Alexander

Alexander combines insights from genetics and spatial transcriptomics to understand how aberrant differentiation of cortical cell types can cause disease symptoms in neurodevelopmental disorders.

Previously, he was a graduate scientist at AstraZeneca, where he contributed to various parts of the drug development process for type 2 diabetes.

Publications

  • No direct effect of SGLT2 activity on glucagon secretion.

    Kuhre RE, Ghiasi SM, Adriaenssens AE, Wewer Albrechtsen NJ, Andersen DB et al.

    Diabetologia 2019;62;6;1011-1023

  • Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.

    Skrtic S, Tyrberg B, Broberg M, Ericsson H, Schnecke V et al.

    PloS one 2018;13;12;e0208998

  • Regulation of the β-cell inflammasome and contribution to stress-induced cellular dysfunction and apoptosis.

    Ghiasi SM, Dahllöf MS, Osmai Y, Osmai M, Jakobsen KK et al.

    Molecular and cellular endocrinology 2018;478;106-114

  • Modeling human pancreatic beta cell dedifferentiation.

    Diedisheim M, Oshima M, Albagli O, Huldt CW, Ahlstedt I et al.

    Molecular metabolism 2018;10;74-86

  • No direct effect of SGLT2 activity on glucagon secretion.

    Kuhre RE, Ghiasi SM, Adriaenssens AE, Wewer Albrechtsen NJ, Andersen DB et al.

    Diabetologia 2019;62;6;1011-1023

  • Regulation of the β-cell inflammasome and contribution to stress-induced cellular dysfunction and apoptosis.

    Ghiasi SM, Dahllöf MS, Osmai Y, Osmai M, Jakobsen KK et al.

    Molecular and cellular endocrinology 2018;478;106-114

  • Modeling human pancreatic beta cell dedifferentiation.

    Diedisheim M, Oshima M, Albagli O, Huldt CW, Ahlstedt I et al.

    Molecular metabolism 2018;10;74-86

  • Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.

    Skrtic S, Tyrberg B, Broberg M, Ericsson H, Schnecke V et al.

    PloS one 2018;13;12;e0208998

Aivazidis, Alexander
Alexander's Timeline
2018

Started as PhD student at Wellcome Sanger Institute

2016

Started as Graduate Scientist at AstraZeneca, Sweden

2015

MPhil in Computational & System Biology at University of Cambridge

2013

Exchange Year at Ecole Polytechnique Federale de Lausanne, Switzerland

2011

Started MSci in Physics at Imperial College London